Low Α-Defensin Gene Copy Number Increases the Risk for IgA Nephropathy and Renal Dysfunction
Zhen Ai,Ming Li,Wenting Liu,Jia-Nee Foo,Omniah Mansouri,Peiran Yin,Qian Zhou,Xueqing Tang,Xiuqing Dong,Shaozhen Feng,Ricong Xu,Zhong,Jian Chen,Jianxin Wan,Tanqi Lou,Jianwen Yu,Qin Zhou,Jinjin Fan,Haiping Mao,Daniel GalUCL,Jonathan Barratt,John AL Armour,Jianjun Liu,Xueqing Yu
DOI: https://doi.org/10.1126/scitranslmed.aaf2106
IF: 17.1
2016-01-01
Science Translational Medicine
Abstract:Abstract: IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. Although being a major source of genetic variation, copy number variations (CNVs) are poorly studied for their involvement in disease development. Here we performed association analysis of DEFA1A3 CNV locus in two independent IgAN cohorts of Southern Chinese Han (total 1189 cases and 1187 healthy controls). We discovered three independent copy number associations within the locus: DEFA1A3 (P=3.99×10-9, OR=0.88), DEFA3 (P=6.55×10-5, OR=0.82) and a noncoding deletion variant (211bp) (P=3.50×10-16, OR=0.75) (OR per copy, fixed-effects meta-analysis). While showing strong association with increased risk for IgAN (P=9.56×10-20), low total copy numbers of the three variants also showed significant association with poor long-term renal survival of IgAN (P=0.03, HR=3.69, after controlling the effects of known prognostic factors) as well as the high serum IgA1 level (P=0.02) and high proportion of galactose-deficient IgA1 (P=0.03). As replication, we confirmed the associations of DEFA1A3 (P=4.42×10-4, OR=0.82) and DEFA3 copy numbers (P=4.30×10-3, OR=0.74) with IgAN in a Caucasian cohort (531 cases and 198controls) and found 211bp variant to be extremely rare in Caucasians. Interestingly, we also observed an association of 211bp copy number with membranous nephropathy (P=1.11×10-7, OR=0.74 in 493 Chinese cases and 500 matched controls), but not with diabetic kidney disease (in 806 Chinese cases and 786 matched controls). By explaining 4.96% of risk variance (the strongest genetic susceptibility locus so far) and influencing the renal progression of IgAN, the DEFA1A3 CNV locus is a potential candidate of novel therapeutic target and prognostic biomarker.